Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q2 2026

Protagenic Therapeutics, Inc.\new Q2 2026 Results: Net Loss of $667K, Loss Narrows

Protagenic Therapeutics reported a net loss of $1,630,810 for the six months ended September 30, 2026, compared to a loss of $5,927,010 in the prior year period. The company's cash position significantly decreased from $1,509,178 at March 31, 2026, to $76,909 at September 30, 2026, as it continues to fund research and development and consulting operations.

Q2 2026 at a glance · $ million
MetricQ2 2026Q2 2025
Profit before tax-0.7-0.9
Net income-0.7-0.9
EPS (diluted, $ a share)$-0.37$-0.47

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, OTC: PTIX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Protagenic Therapeutics, Inc.\new: key numbers

Share price
$0.4500Close, Nov 16
Market cap
$815K
Shares outstanding
1.81MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Protagenic Therapeutics, Inc.\new

All →
4:41 PM ET 8-K
Capital Raise

Protagenic Therapeutics, Inc.\new Capital Raise of $1.5M

Protagenic Therapeutics entered into a securities purchase agreement for a private placement offering of common stock and warrants, raising $1.5 million in initial gross proceeds. The company may raise up to $5 million in total through subsequent closings and the exercise of milestone-linked warrants. Proceeds will be used to fund IND-enabling activities and the initiation of a Phase 1/2a clinical trial for PT00114 in Generalized Anxiety Disorder.

Value
$1.5M
2:16 PM ET 8-K
Loan & Debt

Protagenic Therapeutics, Inc.\new Debt Financing Update with Patness LLC

Protagenic Therapeutics issued a $250,000 promissory note to Patness LLC bearing 1.0% annual interest. The debt is due upon the earlier of a future equity capital raise of at least $1 million or 180 days from the issuance date. Interest is forgiven if the principal is repaid within 365 days.

Counterparty
Patness LLC
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.